Antihypertensives can decrease bleomycin-induced lung injury
Bleomycin is a drug used to treat certain cancers, such as Hodgkin lymphoma and germ…
Browsing: hodgkin lymphoma
Excellent research results for CAR-T Cell therapy against Hodgkin lymphoma
CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been…
Monitoring for breast cancer after childhood chest radiation: When and how?
Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as…
EHA 2020: A new treatment paradigm in relapsed refractory Hodgkin lymphoma
Patients with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) have few treatment options when they are…
EHA 2020: PET-guided therapy allows omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma
For decades, combined modality treatment (CMT) comprising of four cycles of chemotherapy and radiotherapy has…
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma
A new analysis shows that a donor stem cell transplant following treatment with an immune…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
Genetic link found between the immune system and lymphoma
People who inherit genetic changes which alter the function of their immune system are at…
Second cancers deadlier in young patients
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they…
Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a…